Thank you for subscribing!

GPO Plus Inc.

Sustainable Growth QoQ“We are excited to report quarter over quarter continued growth since we became publicly traded. We now have our team in place, products that are in demand, revenue growth, new products in development; that is a great foundation upon which to build our future.” ~ Brett H. Pojunis, CEO.

 

Growth by Acquisition

Seeking superior shareholder returns, GPOX has implemented acquisitions as an integral part of its growth strategy. A great example of how the company will be moving forward is the acquisition of Nutriumph: Brett H. Pojunis, CEO of GPOX stated in a recent Press Release, “The Nutriumph® acquisition is the first direct-to-consumer (DTC) product line GPOX has offered… we feel confident GPOX will expand Nutriumph® sales into retailers and are excited about the future! 

GPOX is aggressively seeking other acquisitions in this space as well as looking for targets for all of our divisions, we feel Nutriumph® gets our company off to a great start!”

A New Kind of GPO – CEO Brett H. Pojunis and GPOPlus+ at large have a timely vision for the future of the company: helping out the consumer by making an impact for small, local businesses. Though still in its early stages of implementation, it’s clear that GPOPlus+ can leverage its experience to make a direct impact on small, local businesses. We’re moving to the manifestation stage.

Leadership w/ Vision and Ability – After it became publicly traded, GPOX continued to grow cbdGPO and then started HealthGPO. Its success attracted an amazing senior management team and provide experience across multiple areas and markets. Leadership has taken GPOX from a limited PINK sheet company to a fully reporting company listed on a national exchange, the OTCQB.

 

Aggregate, Negotiate + Share!

  • Aggregate   aggregate the purchasing power of our members
  • Negotiate –  leverage buying power to negotiate discounts
  • Share –  share the discounts with our Members and save them money

GPOPlus+ (OTCQB: GPOX)  develops industry-specific Group Purchasing Organizations, and its effective, acquisition-based business model has led to nearly $2M in revenue in just two years of operation

GPOs in the United States represent a $5.1B industry in 2022 with a modest 2.6% growth projected for the year, while GPOX is enjoying 12% growth

So let’s talk about what makes GPOPlus+ unique, and how it maintains a growth rate 4x higher than the industry at large. 

Key Investment Considerations 

Targeting Ripe Markets – GPOPlus+ targets underserved industries with the GPOs it forms or companies and products it acquires, such as covid tests for elderly care and other markets with little competition. Acquiring companies in these spaces has allowed GPOX to increase its revenues significantly in a short time, with its sights set on continuing growth. 

Revenue Is Growing – The company saw 160% growth in revenue for Q3 ending January 31, ‘22 compared to ‘21 and topped $1M in revenue for the first time, a major milestone for a young company with massive potential. In fact, it has seen QoQ growth every quarter since becoming publicly traded. For being just two years old, GPOX has come out of the box swinging. 

Equity Crowdfunding With Major Upside Potential – GPOX launched a $5M crowdfunding offering last year. The terms are: $1.5K purchase price/unit, each Unit consisting of 1,000 shares of common stock at $1.50/share and 1K bonus Warrants to buy an additional share of common stock at $2/share. The math isn’t difficult. There is a great deal of profit potential for early investors.

GPOX Quarterly Growth (historical numbers in thousands):

  • $0 10-K for the fiscal year ended: April 30, 2020 (pre-revenue)
  • $6,338 10-Q for the fiscal quarterly period ended July 31, 2020 (Q1 2020)
  • $24,289 10-Q for the fiscal quarterly period ended October 31, 2020 (Q2 2020)
  • $591,757 10-Q for the fiscal quarterly period ended January 31, 2021 (Q3 2021)
  • $204,347 10-K for the fiscal year ended: April 30, 2021
  • $369,558 10-Q for the fiscal quarterly period ended July 31, 2021 (Q1 2021)
  • $229,161 10-Q for the fiscal quarterly period ended October 31, 2021 (Q2 2020)
  • $397,094 10-Q for the fiscal quarterly period ended January 31, 2021 (Q3 2021)

 

“We are excited to report quarter over quarter continued growth since we became publicly traded. We now have our team in place, products that are in demand, revenue growth, new products in development; that is a great foundation upon which to build our future.” ~ Brett H. Pojunis, CEO 

 

Costco Model for Businesses 

A GPO is an entity created to leverage the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO. GPOs negotiate discounted rates from vendors and service providers, which are then passed on to their members. What Costco does for consumers, GPOPlus+ is now doing for businesses.

In short, the more members save, the more revenue GPOPlus+ creates for themselves and their shareholders. The company reported $622k in YTD revenue Q3 of 2020 and recently saw that number increase to $995k by Q3 2021. What’s most promising is the results are proving its business model with consistent growth since going public.

Show me the money! 

GPOX generates revenues from three main areas; agency agreements with manufacturers and service providers, membership fees, and GPO PRO Services.

  1. Agency Agreements – GPOX negotiates contracts directly with manufacturers, producers, distributors, and wholesalers. Revenues are generated from a percentage of the total sales produced.
  2. Membership Fees – Clients (GPOX calls them members) pay a fee (monthly, quarterly, or annually) to have access to quality products and discounts. 
  3. GPO PRO Services – GPOX generates sales from GPO PRO Services which vary based on the service offered.

We’re Seeing Significant Growth in Just Two Years of Operation 

Organic Growth– GPOX identifies products that have a unique value proposition and then enter into distribution agreements to sell and  distribute products , and in some cases will private label / white label existing products under its other brand(s). 

GPOX’s  growth strategy is to expand the number of business units and increase sales teams nationally. GPOX also intends to develop a membership based eCommerce website which sells products commonly purchased by businesses.

Acquisitive Growth – Seeking superior shareholder returns, GPOX has implemented acquisitions as an integral part of its growth strategy.

GPOX has identified a few areas of focus for acquisitions with a focus on consumer packaged goods, independent and regional distribution companies, wholesalers and specialty retailers.  

GPOX acquisition targets are companies that are generating revenues and likely plateaued but GPOX also appealing to these companies because the GPO structures encourage streamlined operations and provide greater opportunity through existing relationships. They have developed technology to help with better purchasing, marketing and overall management.

 

History Tends to Repeat – GPOX’s Past Success Points to A Promising Future

HealthGPO

HealthGPO offers medical supplies and products for the healthcare industry, which has been tremendously valuable during the COVID-19 pandemic and aligned with another aspect of the GPOPlus mission: maintaining sustainable supply chains. 

In response to the mass shortage of COVID-19 tests in 2021, GPOPlus+ launched Antigentests.com. The shortage in the supply chain was leading to both a lack of access as well as inconsistent pricing and significant price increases. Through the project, GPOPlus+ members and point-of-care providers were given competitive, fair pricing and reliable access to POC COVID-19 tests. 

“Shareholders who looked closely at our filings could identify that a large portion of our revenue last year (2021) was derived from POC COVID test sales,” said GPOX CEO Brett H. Pojunis. “The importance of this project (AntigenTests.com) cannot be overstated! This creates an opportunity for us to grow HealthGPO’s Membership because we are in a position to truly help POC healthcare and medical providers who are struggling to get the tests they need.”

cbdGPO

The CBD market has a promising future. It represented just $4.9B in 2021 but is estimated to grow at an impressive 21.7% CAGR through 2028. That creates an opportunity for a $47.22B market in the very near future.

 It is also a perfect example of GPOPlus+ effectively targeting industries in need. As the CBD industry grows, GPOPlus+ can be positioned to supply businesses with quality products as they work to keep up with demand. 

 

GPOX Levels the Playing Field by Helpings the Little Guy

You’ve probably gathered by now, GPOX is really in the business of helping businesses. And small and medium businesses in particular have a lot to gain with GPOX. 

In addition to operating in targeted markets with little to no competition, GPOX provides its members relief from unrealistic MOQ’s (minimum order quantities). As larger GPOs are prone to only do transactions with larger orders — a logical practice that saves overhead but leaves the little guy high and dry — smaller businesses are left in a pinch. They either have to provide a lot of capital upfront to meet high MOQ’s on essential raw materials and finished products, or they’re forced out of the game altogether.

GPOX does this by using the aggregate purchasing power of its members, lowering minimum MOQ’s that are passed on to members. This creates a win-win for everybody — something small and medium businesses don’t come across often. 

This is especially true with its a newer venture, Distro+

Large companies benefit from increased costs as small businesses can’t compete with their buying power – they pay more and are passing those increased costs to their customers.

Once GPOX starts organizing local businesses and creates Group Purchasing programs around commonly purchased items, local businesses will be able to compete, and ultimately they will pass those SAVINGS to their customers. This unique vision is just the type of exciting new business application we look for in an investment opportunity. 

 

The Bottom Line 

Whenever an industry experiences rapid growth and is highly fragmented there is always a consolidation period, and this is when Billion Dollar brands are created. The industries GPOX currently operates in (CBD and Healthcare) are prime examples of fragmented industries that have had significant growth and are ripe for consolidations. 

The Company intends on taking full advantage of this consolidation opportunity by acquiring companies that fit into its portfolio and/or increases its market share. It’s a strategy that has proven success so far, and we think it will continue to benefit GPOX in the future. 

Due to market forces, we think GPOX is an undervalued opportunity that has remained low-cost despite continuing to add more growth, value, revenue, and divisions. As the market stabilizes, we wouldn’t be surprised if GPOX’s value and market cap increased. Premier, Inc., a healthcare GPO, has (at the time of this writing) a stock price of $37.11 and a market cap of $4.3B. GPOX operates in the same spaces and has continued to show sustained growth through services and acquisitions. It isn’t crazy to think that at some point they could be right up there with Premier.

GPOPlus+ is a young company but they are helmed with experience. They are well-managed and thorough, going into stealth mode in 2020 to devise the model we see them putting into action now.  Reporting nearly $2M in revenue in such a short time is great no matter what, but having something that is scalable makes for something exciting — something that GPOPlus+ plans to repeat and execute across multiple industries as they grow. 

 

Press Releases: 

GPOPlus+ Launches New GPO DISTRO+

GPOPlus+ Announced It Filed Its Fiscal Q3 Quarterly Report on Form 10-Q

GPOPlus+ Officially Announces Bryan Garabrandt as Vice President of Sales and Marketing and Chief Technologist

GPOPlus+ Announces the Engagement of Investor Relations Firm

GPOPlus+ Announcing New Chief Operationg Officer and Board Member Wayne Smeal 

GPOPlus+ Announces the Launch of AntigenTests.com, a Project of HealthGPO

GPOPlus+ CEO Outlines Growth Plan and Provides Update to Investment Community in MoneyTV Interview

GPOPlus+ Announces New President and Board Member Ron McCormick  

GPOPlus+ Announces Master Distribution and National Sales Agreement with US BioSolutions for Proprietary BioFoam Technology

GPOPlus+ Names Laurence Ruhe as New Chief Financial Officer 

GPOPlus+ Announces the Launch of $5M Reg D 506c Equity Crowdfunding Offering 

GPOPlus+ Announces Filing of 2021 Annual Report on Form 10-K

GPOPlus+ Exits Stealth Mode With Proof of Concept for Disruptive New Group Purchasing Business Model 

GPOPlus+ Announces Removal of Shell Risk Designation by OTC Markets 

GPOPlus+ Announces Upgrade to OTCQB Venture Market

GPOPLus+ Signs Definitive Distribution Agreement with Exclusive Territories and Industry with SafeHandles 

 

Management

BRETT H. POJUNIS – Chairman of the Board of Directors & Chief Executive

+ Key Strengths: Brett has a strong background in capital markets, finance, technology, marketing, and public company matters with expertise in Investor Relations and extensive entrepreneurial experience as well as board and committee level experience. He also served in the US ARMY

+ Industries: Technology, CBD, Cannabis, Non-Profits, Politics, Capital Markets, and Investor Relations.

 

RONALD McCORMICK – President & Member of the Board of Directors

+ Key Strengths: With 28 years as a Nutritionist focusing on health, wellness, and fitness, Ron developed and pioneered some of the most popular supplements nationwide generating millions of dollars in annual revenue. 7 years ago, he began to apply his experience, network, and expertise to the new CBD industry.

+ Industries: Nutrition, Health & Wellness, Fitness, CBD, Dietary Supplements & Nutritional Science.

 

LAURENCE RUHE – Chief Financial Officer

+ Key Strengths: Larry Ruhe is a seasoned professional with extensive experience in the capital markets driving strong financial and operational results for publicly traded and private companies. Mr. Ruhe has international business experience working with multi-national enterprises operating in multiple countries with multiple currencies.

+ Industries: Finance, Operations, Gaming, Capital Markets, International Currency, Banking, and Investor Relations.

 

WAYNE SMEAL – Chief Operating Officer & Member of the Board of Directors

+ Key Strengths: Wayne has Strategic Management, Business and Distributor Development, experience building management teams and growing successful companies. He built National and International Franchise Operations in multiple industries within his 30 plus years of experience.

+ Industries: CBD, Franchising, Commercial Development, Indoor Tanning, Cigars, Frozen Foods, Wine & Spirits, Packaged Meats, Healthcare & Medical Products.

 

MICHAEL R. FUGLER – Advisor

+ Key Strengths: Michael has planned, advised, managed, co-managed, underwritten, and/or been a syndicate member or participant in hundreds of offerings, raising hundreds of millions of dollars for hundreds of clients, listing many on senior US and Foreign Stock Exchanges. He helps entrepreneurs build companies and provides out of the box solutions and problem solving.

+ Industries: Capital Markets, Legal, Deal Structure, Technology, and Public Companies.

 

BRYAN GARABRANDT – Director of Sales + Marketing, Chief Strategist

+ Key Strengths: Bryan’s background is in consumer and b2b direct sales and marketing, and analytics. As a technologist and trained statistician, he puts his trust in the data and believes having quality analytics in order to make calculated decisions is the best approach to great marketing and strong ROI. Bryan has managed and supported sales organizations across multiple industries.

+ Industries: Psychology, Marketing and Branding, Technology, Direct Sales, CBD, and Investor Relations.

 

KEVIN MALONE –  Advisor

+ Key Strengths: For over 34 years, Kevin specialized in market making by providing liquidity and execution services for institutions and broker-dealers. He is widely recognized for building and managing OTC Trading Desks and held senior positions at Frankel Securities, Aegis Capital, and R.F. Lafferty. He also participated in or led M&A activities. Kevin held FINRA Series 7, 24, 63 & 55 licensed.

+ Industries: Capital Markets, Market Making, Technology, and Finance.

 

 

 

DISCLAIMER

Who are we and what do we do? We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (the “Information”) about publicly traded companies (the “Profiled Issuers”). How is the Information published? We publish the Information on our Website, in newsletters, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer or third party paying us. Our publication of the Information is known as a “Campaign”. Will everyone receive the Information at the same time? No. The Information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. How is a potential investor impacted if he receives the Information later than other investors? Typically, the trading volume and price of a Profiled Issuer’s securities increases after the Information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer increased trading losses if he purchases the securities of a Profiled Issuer. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase during the Campaign. What will happen when the Campaign ends? Most, if not all, of the Profiled Issuers are penny stocks that are illiquid and whose securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profiled Issuer will likely increase significantly. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment. Why do we publish only favorable Information? We only publish favorable information because we are compensated to publish only favorable information. Why don’t we publish negative Information? We don’t publish negative information because we are not paid to publish negative information. We are paid to publish only favorable information. Is the Information complete, accurate, truthful or reliable? No. The Information is a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful or reliable. What we do not do? We do not publish negative information about the Profiled Issuers. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities. Where does the Information come from? The Information is provided to us by the Profiled Issuers and/or the person who hires us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, the Securities and Exchange Commission’s Edgar database or other available public sources. If we say we make “stock picks,” are those picks our own? No, they are not. We are compensated to advertise the securities we are told to advertise. What will happen if an investor relies on the Information? If an investor relies on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision. Who pays us to publish the Information? The source of our compensation varies depending upon the particular circumstances of the Campaign. We are compensated by the Profiled Issuers, third party shareholders and other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities. The nature and amount of compensation we receive for publishing the Information about each Profiled Issuer and our ownership of each Profiled Issuer is set forth below under the heading captioned, “What we are compensated”. What warranties do we make about the Information? None. We make no warranty or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation. What we are not. We are not and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following:
  • An independent adviser or consultant;
  • A fortune teller;
  • An investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal or state level;
  • A broker-dealer or an individual acting in the capacity of a registered representative or broker;
  • A stock picker;
  • A securities trading expert;
  • A securities researcher or analyst;
  • A financial planner or one who engages in financial planning;
  • A provider of stock recommendations;
  • A provider of advice about buy, sell or hold recommendations as to specific securities; or
  • An agent offering or securities for sale or soliciting their purchase.
Are risks in this disclaimer the only risks investors should be aware of? No. There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer. What conflicts of interest do we have in publishing the Information? We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase. Our publication of the Information involves actual and material conflicts of interest including but not limited to the following:
  • We receive monetary and/or securities compensation in exchange for publishing the (favorable) Information about the Profiled Issuers;
  • We do not publish any negative information whatsoever about the Profiled Issuers;
  • We may own a Profiled Issuer’s securities that we acquired from the Profiled Issuer, third parties or from our own open market purchases before, during or after the Campaign and we may sell these securities during the Campaign while publishing the (favorable) information that instructs investors to purchase. Our selling of a Profiled Issuer’s securities will likely cause investors to suffer losses;
  • A short time after we acquire a Profiled Issuer’s securities, we may publish the (favorable) Information about the Profiled Issuer advising others, including you, to purchase; and while doing so, we may sell the Profiled Issuer’s securities we acquired during our public dissemination of the Information causing us to profit while you suffer a loss;
  • Parties holding a Profiled Issuer’s securities, including those who engage our services and/or compensate us, will sell their shares of the Profiled Issuer while we are publishing the (favorable) Information.
Who is responsible if an investor relies on the Information? The investor. We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions or errors in the Information, and we are not responsible for actions taken by any person who relies upon the Information. What do we urge potential investors to do? We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, OTC Markets, NASDAQ, NYSE, www.sec.gov or other available public sources. Why is this Disclaimer being provided? We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose our compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell our own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns. What are other risks that investors should be aware of? Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.
  • We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.
  • If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.
  • The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.
  • The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.
  • You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.
  • We or other stock promoters may receive free trading shares as compensation or we may acquire such shares in open market transactions before and during the Campaigns, and we may sell the shares we acquire at any time, even during the Campaigns while publishing the Favorable Information. When we sell the shares of the Profiled Issuers that we hold, the price at which investors can sell their shares will dramatically decrease and will likely cause investors to suffer trading losses.
  • We may sell securities of the Profiled Issuers for less than target prices set forth in the Information, and we may profit by selling our securities during the Campaigns while investors encounter losses.
  • When we acquire, purchase or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit us to make substantial profits while investors who purchase during the Campaign experience significant losses.
  • The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.
  • If we are compensated in improperly free trading securities of the Profiled Issuers, either directly or indirectly from persons who claim to be non-affiliates of such Profiled Issuer, we and the Profiled Issuer or third party could be subject to SEC Enforcement Action, including allegations of an illegal distribution in violation of Section 5(a) and 5(c) of the Securities Act.
  • We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and fail to disclose their compensation to you.
If a Profiled Issuer is an SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at www.otcmarkets.com, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions. If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies. The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.govwww.sec.gov, www.otcmarkets.com or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the OTCMarkets.com; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.org. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at otcmarkets.com. What we were paid to advertise the Profiled Issuers. The details of our compensation and the period of the Campaign is set forth below.
  • Name of Issuer & Ticker Symbol - GPO Plus, Inc. (GPOX)
  • Amount & Form of Compensation - $400,000 in Restricted Common Stock
  • Who Paid for the Campaign & Position with Company if any - GPO Plus, Inc. (GPOX)
  • Period of Campaign - 05/04/2022 - 05/04/2023
What securities of the Profiled Issuers do we hold? The positions we hold of the Profiled Issuer are set forth below. We plan to sell these securities during the Campaign.
  • Name of Issuer & Ticker Symbol - GPO Plus, Inc. (GPOX)
  • Number of Shares We or our Affiliates Hold - 1,002,506
  • Price We Paid Per Share - $0
  • Date Issued - 05/05/2022

Related Post

Register to Download Presentation

Go to website

Join the club

Subscribe to this newsletter

This email is already subscribed.

Go to top